Rossari Biotech (NSE:ROSSARI) LT-Debt-to-Total-Asset: 0.05 (As of Mar. 2026)


NSE:ROSSARI Rossari Biotech Ltd NSE:ROSSARI
87 GF Score
Price ₹516.45
GF Value ₹1,002.70
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech LT-Debt-to-Total-Asset?

Rossari Biotech NSE:ROSSARI -2.75% 87 LT-Debt-to-Total-Asset is 0.05 as of Mar. 2026. GuruFocus rates NSE:ROSSARI with a GF Score™ of 87/100 and a GF Value™ of ₹1,002.70 (Possible Value Trap). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Rossari Biotech's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.05.

Rossari Biotech's long-term debt to total assets ratio declined from Mar. 2025 (0.07) to Mar. 2026 (0.05). It may suggest that Rossari Biotech is progressively becoming less dependent on debt to grow their business.

Rossari Biotech  (NSE:ROSSARI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Rossari Biotech LT-Debt-to-Total-Asset Related Terms

Rossari Biotech LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Rossari Biotech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossari Biotech LT-Debt-to-Total-Asset Chart

Rossari Biotech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only 0.00 0.03 0.03 0.07 0.05

Rossari Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.00 0.07 0.00 0.05
NSE:ROSSARI
87GF Score
Rossari Biotech Ltd NSE:ROSSARI
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossari Biotech LT-Debt-to-Total-Asset Calculation

Rossari Biotech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=1145.79/22887.92
=0.05

Rossari Biotech's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=1145.79/22887.92
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.05 mean?
Rossari Biotech (NSE:ROSSARI) has a LT-Debt-to-Total-Asset of 0.05 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Rossari Biotech and its competitors.
Is Rossari Biotech's LT-Debt-to-Total-Asset too high?
Rossari Biotech's current LT-Debt-to-Total-Asset is 0.05. Overall, Rossari Biotech has a GF Score™ of 87/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's LT-Debt-to-Total-Asset compare to LIN and SHW?
Rossari Biotech's LT-Debt-to-Total-Asset of 0.05 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Chemicals company?
A good LT-Debt-to-Total-Asset depends on the Chemicals industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Rossari Biotech and its competitors. Rossari Biotech's current LT-Debt-to-Total-Asset is 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,002.70, compared to a current price of ₹516.45 — trading 48.5% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.05. Rossari Biotech's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current LT-Debt-to-Total-Asset is 0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹516.45 is trading 48.5% below its estimated GF Value™ of ₹1,002.70. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for NSE:ROSSARI:

  • LT-Debt-to-Total-Asset: 0.05
  • GF Value™: ₹1,002.70 vs. price of ₹516.45 (48.5% below fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rossari Biotech Business Description

Other Exchanges 543213:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
87GF Score

Get the complete analysis for NSE:ROSSARI

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹516.45
Price
₹1,002.70
GF Value